Evidence map›Paper›PMID 41663154›Full record

ArticleGut2026

Yan Yang, Rui Yang, Yiran Chen, Chao He, Yingzi Zhang, Jing He, Jing Zhang, Haohao Wang, Jingdan Liang, Zixin Deng and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Gut, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yan Yang *Department of Surgical Oncology, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China lsteng@zju.edu.cn yangyan1222@zju.edu.cn zxdeng@sjtu.edu.cn jdliang@sjtu.edu.cn.ORCID http://orcid.org/0009-0008-0237-9188
Rui Yang *Department of Surgical Oncology, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Yiran ChenDepartment of Surgical Oncology, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Chao HeDepartment of Surgical Oncology, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Yingzi ZhangDepartment of Surgical Oncology, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Jing HeDepartment of Surgical Oncology, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Jing ZhangDepartment of Surgical Oncology, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Haohao WangDepartment of Surgical Oncology, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Jingdan LiangState Key Laboratory of Microbial Metabolism, Joint International Research Laboratory of Metabolic & Developmental Sciences, and School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China lsteng@zju.edu.cn yangyan1222@zju.edu.cn zxdeng@sjtu.edu.cn jdliang@sjtu.edu.cn.
Zixin DengState Key Laboratory of Microbial Metabolism, Joint International Research Laboratory of Metabolic & Developmental Sciences, and School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China lsteng@zju.edu.cn yangyan1222@zju.edu.cn zxdeng@sjtu.edu.cn jdliang@sjtu.edu.cn.
Lisong TengDepartment of Surgical Oncology, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China lsteng@zju.edu.cn yangyan1222@zju.edu.cn zxdeng@sjtu.edu.cn jdliang@sjtu.edu.cn.ORCID http://orcid.org/0000-0001-6470-9017

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGastric cancer (GC) is one of the most common malignancies worldwide and it is the third leading cause of cancer-related death in China. While

objectiveWe aim to investigate the mechanisms of other bacteria influencing GC progression and metastasis.

designIntegrated intratumoural microbiome-metabolome analysis identified GC-associated microbes and metabolites. We then demonstrated the pro-metastatic role of

resultsThe abundance of

conclusionsThis study elucidates the role of

Indexed as

Acinetobacter baumanniiNADNiacinStomach NeoplasmsAnimalsCell Line, TumorGlycolysisHumansMetabolic ReprogrammingMiceNeoplasm MetastasisNADNiacinENERGY METABOLISMGASTRIC CANCERINTESTINAL MICROBIOLOGY

Identifiers

PMID41663154
PMCPMC13638492

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.